WebWe collaborate closely with healthcare professionals and the world's leading research institutes and pharmaceutical companies. Together we create reliable drugs and well … WebCompany Description Fermion develops, manufactures and markets active pharmaceutical ingredients (APIs) to companies in global generic market as well as under exclusive contracts to companies focusing on new chemical entities (NCEs). Fermion is fully owned subsidiary of Orion Corporation and headquartered in Espoo, Finland.
Fermion Oy LinkedIn
WebFermion is particularly well-known as a manufacturer of highly potent active pharmaceutical ingredients requiring special competence, including those applied in cancer drugs. Almost 100 per cent of its production is exported either directly or as part of Orion's medications. WebOrion develops, manufactures and markets human and veterinary pharmaceuticals, active pharmaceutical ingredients, and diagnostic tests. Orion currently employs 3,500 people, and has sales offices around Europe. Fermion is a subsidiary fully owned by Orion, which concentrates on research and manufacturing of APIs. ragreage p4s uzin
EDQM & GMP Inspections, European Inspections Database
WebFormed in 1970 as a joint venture between Rikkihappo Oy (now Kemira Oy) and Orion, Fermion produces generic APIs, intermediates and active ingredients for both Orion and … WebMay 18, 2024 · Fermion is a leading global pharmaceutical substance manufacturer based in Finland. Credit: Estormiz. Finland-based pharmaceutical company Fermion is … WebFermion focuses on providing artificial intelligence (AI)-assisted pharmaceutical technology platform for small molecule drugs. The company's products and services include fulmz … drawback\u0027s 7q